|
| 1 |
Anti–PD-L1 Antibody and/or 17β-Estradiol Treatment Induces Changes in the Gut Microbiome in MC38 Colon Tumor Model
Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Jae Young Jang, Jina Choi, Ha-Na Lee
Cancer Res Treat.2023;55(3):894-909. Published online 2023 January 9
DOI: http://dx.doi.org/10.4143/crt.2022.1427
|
|
| 2 |
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature
Wei Lin Tay, Donovan Tay
Endocrinol Metab.2022;37(2):183-194. Published online 2022 April 14
DOI: http://dx.doi.org/10.3803/EnM.2021.1369
|
|
| 3 |
Glasgow prognostic score and combined positive score for locally advanced rectal cancer
Yanru Feng, Jialin Luo, Peng Liu, Luying Liu, Yuan Zhu, Guoping Cheng, Linfeng Zheng
|
|
| 4 |
Changes in Serum Dickkopf-1, RANK Ligand, Osteoprotegerin, and Bone Mineral Density after Allogeneic Hematopoietic Stem Cell Transplantation Treatment
Eunhee Jang, Jeonghoon Ha, Ki-Hyun Baek, Moo Il Kang
Endocrinol Metab.2021;36(6):1211-1218. Published online 2021 December 8
DOI: http://dx.doi.org/10.3803/EnM.2021.1248
|
|
| 5 |
Immunohistochemical expression of programmed death-ligand 1 and CD8 in glioblastomas
Dina Mohamed El Samman, Manal Mohamed El Mahdy, Hala Sobhy Cousha, Zeinab Abd El Rahman Kamar, Khaled Abdel Karim Mohamed, Hoda Hassan Abou Gabal
|
|
| 6 |
Soluble CD40 Levels in Plasma Are Associated with Cardiovascular Disease and in Carotid Plaques with a Vulnerable Phenotype
Annelie Shami, Andreas Edsfeldt, Eva Bengtsson, Jan Nilsson, Angela C. Shore, Andrea Natali, Faisel Khan, Esther Lutgens, Isabel Gonçalves
J Stroke.2021;23(3):367-376. Published online 2021 September 30
DOI: http://dx.doi.org/10.5853/jos.2021.00178
|
|
| 7 |
An update on immunotherapy with PD-1 and PD-L1 blockade
Sung Ae Koh
|
|
| 8 |
Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Experience over 25 Years and Evaluation of PD-L1 Expression
Heejung Chae, Jeong Eun Kim, Wanlim Kim, Jong-Seok Lee, Si Yeol Song, Min Hee Lee, Hye Won Chung, Kyung-Ja Cho, Joon Seon Song, Jin-Hee Ahn
|
|
| 9 |
Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
Jee Hee Yoon, Min-ho Shin, Hee Nam Kim, Wonsuk Choi, Ji Yong Park, A Ram Hong, Hee Kyung Kim, Ho-Cheol Kang
|
|
| 10 |
Programmed cell death-ligand 1 assessment in urothelial carcinoma: prospect and limitation
Kyu Sang Lee, Gheeyoung Choe
|
|
| 11 |
TL1A/TNFR2 Axis Enhances Immunoregulatory Effects of Bone Marrow Derived Mesenchymal Stem Cell by Indian Hedgehog Signaling Pathway
Mahmoud Al-Azab, Williams Walana, Jing Wei, Weiping Li, Yawei Tang, Xiaoqing Wei, Marwan Almoiliqy, Abdullah Shopit, Elrayah Eltahir Abbas, Salah Adlat, Mohammed Awsh, Xia Li, Bing Wang
Int J Stem Cells.2020;14(1):58-73. Published online 2020 October 31
DOI: http://dx.doi.org/10.15283/ijsc19121
|
|
| 12 |
T Cells Modified with CD70 as an Alternative Cellular Vaccine for Antitumor Immunity
Sang-Eun Lee, A-Ri Shin, Hyun-Jung Sohn, Hyun-Il Cho, Tai-Gyu Kim
Cancer Res Treat.2020;52(3):747-763. Published online 2020 February 14
DOI: http://dx.doi.org/10.4143/crt.2019.721
|
|
| 13 |
Peripheral blood immune cell-based biomarkers in anti-PD-1/PD-L1 therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 10
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
| 14 |
Programmed death-ligand 1 expression and its correlation with clinicopathological parameters in gallbladder cancer
Ji Hye Kim, Kyungbin Kim, Misung Kim, Young Min Kim, Jae Hee Suh, Hee Jeong Cha, Hye Jeong Choi
|
|
| 15 |
Peripheral Blood Immune Cell-based Biomarkers in Anti-PD-1/PD-L1 Therapy
Kyung Hwan Kim, Chang Gon Kim, Eui-Cheol Shin
Immune Netw.2020;20(1):e8. Published online 2020 February 4
DOI: http://dx.doi.org/10.4110/in.2020.20.e8
|
|
| 16 |
Chimeric Antigen Receptor T Cell Therapy: A Novel Modality for Immune Modulation
Somy Yoon, Gwang Hyeon Eom
Chonnam Med J.2020;56(1):6-11. Published online 2020 January 22
DOI: http://dx.doi.org/10.4068/cmj.2020.56.1.6
|
|
| 17 |
PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
Yujun Park, Jiwon Koh, Hee Young Na, Yoonjin Kwak, Keun-Wook Lee, Sang-Hoon Ahn, Do Joong Park, Hyung-Ho Kim, Hye Seung Lee
Cancer Res Treat.2020;52(3):661-670. Published online 2020 January 10
DOI: http://dx.doi.org/10.4143/crt.2019.718
|
|
| 18 |
Prognostic Value of Combined Programmed Cell Death 1 Ligand and p16 Expression Predicting Responsiveness to Radiotherapy in Patients with Oropharyngeal Squamous Cell Carcinoma
Minsu Kwon, Dae Hwan Kim, Ki Ju Cho, Youngchul Kim, Jin Pyeong Kim, Bae Kwon Jeong, Jong Sil Lee, Ji-Hyun Seo, Jung Je Park
|
|
| 19 |
Cancer Immunotherapy Related Endocrine Adverse Effects
Hana Kim, Sun Wook Cho, Young Joo Park
|
|
| 20 |
Tumor immune response and immunotherapy in gastric cancer
Yoonjin Kwak, An Na Seo, Hee Eun Lee, Hye Seung Lee
|
|
